Novartis AG
Utility Patent Applications

Last updated:

List of all Novartis AG patents 676 in total

Status Patent
Application
Utility: BIS 2'-5'-RR-(3'F-A)(3'F-A) CYCLIC DINUCLEOTIDE COMPOUND AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA External link
Filling date: 23 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY External link
Filling date: 23 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: POLYOMAVIRUS NEUTRALIZING ANTIBODIES External link
Filling date: 23 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: FILLING ADAPTER AND INJECTION SOLUTION TRANSFERRING SYSTEM External link
Filling date: 23 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: INJECTION DEVICE AND INJECTION SOLUTION TRANSFERRING SYSTEM External link
Filling date: 23 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: CRYSTALLINE FORMS OF 4-(2-((1R,2R)-2-HYDROXYCYCLOHEXYLAMINO)BENZOTHIAZOL-6-YLOXY)-N-METHYLPICO- LINAMIDE External link
Filling date: 23 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: SYRINGE External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: METHODS OF SELECTIVELY TREATING ASTHMA USING IL-13 ANTAGONISTS External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: OCULAR IMPLANT WITH STIFFNESS QUALITIES, METHODS OF IMPLANTATION AND SYSTEM External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: HSA-GDF-15 FUSION POLYPEPTIDE AND USE THEREOF External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: METHODS FOR PREVENTING AND TREATING URINARY INCONTINENCE External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: BISPECIFIC ANTIBODIES THAT BIND CD 123 CD3 External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: BCMA-TARGETING AGENT, AND COMBINATION THERAPY WITH A GAMMA SECRETASE INHIBITOR External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF External link
Filling date: 23 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS External link
Filling date: 23 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: THERAPEUTIC REGIMEN External link
Filling date: 23 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: DOSAGE REGIMENS OF ANTI-LAG-3 ANTIBODIES AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: ANTIBODY MOLECULES TO CD73 AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: IMMUNOGLOBULIN FRAMEWORKS WHICH DEMONSTRATE ENHANCED STABILITY IN THE INTRACELLULAR ENVIRONMENT AND METHODS OF IDENTIFYING SAME External link
Filling date: 23 Sep 2025 Issue date: 28 May 2020
Application
Utility: CYCLIC TETRAMER COMPOUNDS AS PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS External link
Filling date: 23 Sep 2025 Issue date: 28 May 2020
Application
Utility: CRYSTALLINE FORMS OF 5-BROMO-2,6-DI(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE AND NEW SALTS External link
Filling date: 23 Sep 2025 Issue date: 28 May 2020
Application
Utility: ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST AND COMBINATION THERAPIES External link
Filling date: 23 Sep 2025 Issue date: 28 May 2020
Application
Utility: SILICONE HYDROGEL LENS WITH A CROSSLINKED HYDROPHILIC COATING External link
Filling date: 23 Sep 2025 Issue date: 21 May 2020
Application
Utility: THERAPEUTIC COMBINATION OF A THIRD GENERATION EGFR TYROSINE KINASE INHIBITOR AND A CYCLIN D KINASE INHIBITOR External link
Filling date: 23 Sep 2025 Issue date: 21 May 2020
Application
Utility: USE OF IL-1 BETA BINDING ANTIBODIES FOR TREATING PERIPHERAL ARTERIAL DISEASE External link
Filling date: 23 Sep 2025 Issue date: 14 May 2020
Application
Utility: NOVEL DIAMINO PYRIDINE DERIVATIVES External link
Filling date: 23 Sep 2025 Issue date: 7 May 2020
Application
Utility: TREM2 STABILIZING ANTIBODIES External link
Filling date: 23 Sep 2025 Issue date: 7 May 2020
Application
Utility: ELECTRONIC DEVICES AND METHODS FOR TREATMENT UTILIZING ANTIPSYCHOTICS IN COMBINATION WITH DIGITAL THERAPIES External link
Filling date: 23 Sep 2025 Issue date: 7 May 2020
Application
Utility: TREATMENT OF CANCER WITH A PI3K INHIBITOR IN A PATIENT PRESELECTED FOR HAVING A PIK3CA MUTATION IN THE CTDNA External link
Filling date: 23 Sep 2025 Issue date: 7 May 2020
Application
Utility: ANTIBODY DRUG CONJUGATES External link
Filling date: 23 Sep 2025 Issue date: 30 Apr 2020
Application
Utility: NOVEL PHARMACEUTICAL COMPOSITION External link
Filling date: 23 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: THE USE OF A H3R INVERSE AGONIST FOR THE TREATMENT OF SHIFT WORK DISORDER External link
Filling date: 23 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: SGLT1/2 INHIBITOR LIK066 FOR TREATING OBESITY External link
Filling date: 23 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: INJECTOR DEVICE External link
Filling date: 23 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: FUSED TRICYCLIC PYRIDAZINONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS External link
Filling date: 23 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: APPARATUS FOR MODELLING OCULAR STRUCTURES External link
Filling date: 23 Sep 2025 Issue date: 16 Apr 2020
Application
Utility: NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS COMPRISING A CD20 BINDING DOMAIN External link
Filling date: 23 Sep 2025 Issue date: 16 Apr 2020
Application
Utility: FACTOR XI ANTIBODIES AND METHODS OF USE External link
Filling date: 23 Sep 2025 Issue date: 16 Apr 2020
Application
Utility: ANTIBODY-CYTOKINE ENGRAFTED PROTEINS AND METHODS OF USE FOR IMMUNE RELATED DISORDERS External link
Filling date: 23 Sep 2025 Issue date: 16 Apr 2020
Application
Utility: INJECTOR DEVICE External link
Filling date: 23 Sep 2025 Issue date: 16 Apr 2020
Application
Utility: MESENCHYMAL STEM CELL DIFFERENTIATION External link
Filling date: 23 Sep 2025 Issue date: 9 Apr 2020
Application
Utility: SURGICAL SYSTEM WITH SUBSTANCE DELIVERY SYSTEM External link
Filling date: 23 Sep 2025 Issue date: 9 Apr 2020
Application
Utility: USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS External link
Filling date: 23 Sep 2025 Issue date: 9 Apr 2020
Application
Utility: SUSTAINED DELIVERY OF ANGIOPOETIN-LIKE 3 POLYPEPTIDES External link
Filling date: 23 Sep 2025 Issue date: 9 Apr 2020
Application
Utility: 5,6-FUSED-BICYCLIC COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES External link
Filling date: 23 Sep 2025 Issue date: 9 Apr 2020
Application
Utility: MEDICAL DEVICE, PROGRAMMING DEVICE, WIRELESS TERMINAL, AND MEDICAL SYSTEM External link
Filling date: 23 Sep 2025 Issue date: 9 Apr 2020
Application
Utility: SYSTEM FOR ADMINISTERING A PHARMACEUTICAL PRODUCT External link
Filling date: 23 Sep 2025 Issue date: 9 Apr 2020

Showing 450 to 500 of 676 patents.